Form D — MapLight Therapeutics, Inc.
0001231919-25-000129 · filed Jul 28, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Reported offering amount
- $372,449,989
- Reported amount sold
- $188,187,915
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- MapLight Therapeutics, Inc.
- CIK
- 1770069
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 800 CHESAPEAKE DRIVE
REDWOOD CITY, CA 94063 - Phone
- 650-839-4360
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Christopher A Kroeger · Executive OfficerRedwood City, CA Find on LinkedIn ↗
-
George Pavlov · DirectorRedwood City, CA Find on LinkedIn ↗
-
Timothy Garnett · DirectorRedwood City, CA Find on LinkedIn ↗
-
James Lillie · Executive OfficerRedwood City, CA Find on LinkedIn ↗
-
Peter Bisgaard · DirectorRedwood City, CA Find on LinkedIn ↗
-
Jonathan Gillis · Executive OfficerRedwood City, CA Find on LinkedIn ↗
-
Vishwas Setia · Executive OfficerRedwood City, CA Find on LinkedIn ↗
-
Jim Trenkle · DirectorRedwood City, CA Find on LinkedIn ↗
-
Maria Walker · DirectorRedwood City, CA Find on LinkedIn ↗
-
Kristopher Hanson · Executive OfficerRedwood City, CA Find on LinkedIn ↗
-
Nanna Luneborg · DirectorRedwood City, CA Find on LinkedIn ↗
-
Erin Foff · Executive OfficerRedwood City, CA Find on LinkedIn ↗
-
Anatol Kreitzer · Executive OfficerRedwood City, CA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗